Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 801-093-8 | CAS number: 1315251-11-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
- Acute oral toxicity: LD50 is 500 mg/kg bw in an OECD TG 423
- Acute inhalation toxicity: LC50 is >5.02 mg/L in an OECD TG 403
- Acute dermal toxicity: LD50 is >2000 mg/kg bw in an OECD TG 402
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 500 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- > 5.02 mg/L air
- Physical form:
- inhalation: dust / mist
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Acute toxicity oral (OECD 423):
The study was performed according to OECD TG 423, conducted in compliance with GLP, to assess the acute oral toxicity of the substance in the Wistar strain rat. A group of three fasted females was treated with the substance at a dose level of 300 mg/kg body weight. Based on the results from this dose level, further groups of fasted females were treated at dose levels of 300 and 2000 mg/kg body weight. Dosing was performed sequentially. The substance was administered orally as a suspension in arachis oil BP. Clinical signs and body weight development were monitored during the study. All animals were subjected to gross necropsy.
The animals treated at a dose level of 2000 mg/kg were killed for humane reasons, four hours after dosing, due to the occurrence of clinical signs of toxicity that exceeded the severity limit set forth in the UK Home Office Project Licence. There were no deaths at a dose level of 300 mg/kg. Signs of systemic toxicity noted in animals treated at a dose level of 2000 mg/kg were hunched posture, ataxia, lethargy, body tremors, or occasional body tremors, hypothermia, decreased respiratory rate, clonic and tonic convulsions, splayed gait and ptosis. There were no signs of systemic toxicity at a dose level of 300 mg/kg. Surviving animals showed expected gains in body weight. White liquid present in the stomach was noted in animals treated at a dose level of 2000 mg/kg. No abnormalities were noted at necropsy of animals treated at a dose level of 300 mg/kg.
In conclusion, the acute oral median lethal dose (LD50) of the substance in the female Wistar strain rat was approximately 500 mg/kg body weight.
Acute toxicity inhalation (OECD 403):
A study was performed to assess the acute inhalation toxicity of the substance according to OECD TG 403. A group of 10 RccHan™: WIST strain rats (5 males and 5 females) was exposed to a dust atmosphere. The animals were exposed for 4 hours using a nose only exposure system, followed by a 14 day observation period.
The particulate concentration achieved was measured gravimetrically and found to be 5.02 mg/L The test atmosphere had a mass median aerodynamic diameter of 7.04 µm and a geometric standard deviation (GSD) of 2.59; the inhalable content (%<4 µm) was 27.5%.
Common abnormalities noted during the study included increased respiratory rate, hunched posture, pile-erection and wet fur. There were frequent instances of tip-toe gait and occasional instances of ataxia and red/brown staining around the snout. Isolated occurrences of decreased respiratory rate, laboured respiration, dehydration, diuresis, dehydration, ptosis and occasional body tremors were also noted. The surviving animals recovered to appear normal from days 6 to 11 post-exposure. All animals exhibited body weight losses on the first day post-exposure. All male animals exhibited body weight gains during the remainder of the recovery period. In contrast, all surviving female animals exhibited further body weight losses or showed no body weight gains from days 1 to 3 post-exposure. The surviving animals then exhibited body weight gains during the remainder of the recovery period. With the exception of one instance of dark patches on the lungs, no macroscopic abnormalities were detected at necropsy amongst animals that survived until the end of the fourteen day recovery period.
Based on these results, the LC50 is determined to be greater than 5.02 mg/L.
Acute toxicity dermal (OECD 402):
The study was performed to assess the acute dermal toxicity of the substance in the Wistar strain rat. Initially, two animals (one male and one female) were given a single, 24 hour, semi occluded dermal application of the substance to intact skin at a dose level of 2000 mg/kg body weight. Based on the results of the initial test, a further group of eight animals (four males and four females) was similarly treated. Clinical signs and body weight development were monitored during the study. All animals were subjected to gross necropsy.
Results showed that there were no deaths. There were no signs of systemic toxicity. Very slight erythema was noted at the test sites of three females. Small superficial scattered scabs and scab lifting to reveal glossy skin were also noted at the test site of one female. There were no signs of dermal irritation noted at the test sites of the remaining animals. All animals showed expected gains in body weight. No abnormalities were noted at necropsy.
In conclusion, the acute dermal median lethal dose (LD50) of the substance in the Wistar strain rat was found to be greater than 2000 mg/kg body weight. The substance does not meet the criteria for classification according to the Globally Harmonized System of Classification and Labeling of Chemicals and Regulation (EC) No 1272/2008, relating to the Classification, Labeling and Packaging of Substances and Mixtures.
Justification for classification or non-classification
The substance needs to be classified for acute oral toxicity, category 4, based on an LD50 of 500 mg/kg bw and labelled with H302: Harmful if swallowed according to EU CLP Regulation (EC No. 1272/2008 and its amendments).
The substance does not need to be classified for acute inhalation toxicity based on LC50 >5020 mg/m3 according to EU CLP (EC 1278/2008 and its amendments).
The substance does not need to be classified for acute dermal toxicity based on an LD50 >2000 mg/kg bw according to EU CLP (EC 1278/2008 and its amendments).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.